News-Medical.Net on MSN
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
By Hugo Francisco de Souza Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial ...
A randomized controlled study found that time-restricted feeding—a form of intermittent fasting—significantly reduced symptomatic disease activity and systematic inflammation in adults with Crohn's ...
More cases of colorectal cancer are detected at an early stage with screening. This is according to new research based on data from over 278,000 60-year-olds, who were randomly selected to undergo one ...
A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.
DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...
Randomized, blinded clinical study evaluating injectable autologous hair follicle secretome in patients with androgenic ...
‘A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial’ by David Erritzoe et al. was published in Nature Medicine at 16:00 UK time on ...
The Rapid RCT Lab is a nationally-leading team conducting innovative, rapid RCTs to improve the delivery of services at the ...
The Rapid RCT Lab has worked with 16 departments across NYU Langone and completed 47 trials, and we are currently involved in ...
Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results